WO2009119992A3 - Percutaneous preparation comprising fentanyl - Google Patents
Percutaneous preparation comprising fentanyl Download PDFInfo
- Publication number
- WO2009119992A3 WO2009119992A3 PCT/KR2009/001399 KR2009001399W WO2009119992A3 WO 2009119992 A3 WO2009119992 A3 WO 2009119992A3 KR 2009001399 W KR2009001399 W KR 2009001399W WO 2009119992 A3 WO2009119992 A3 WO 2009119992A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- fentanyl
- crovol
- polyethyleneglycol
- polyethylene glycol
- oleyl alcohol
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Dermatology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
The present invention relates to a matrix-shaped percutaneous preparation comprising fentanyl, which has at least one kind of penetration enhancer for increasing absorptivity of fentanyl and relieving patient’s pain for a long time. The penetration enhancer is selected from the group consisting of polyglyceryl-3 oleate (Plurol oleique cc497®), polyethyleneglycol-20 almond glyceride (Crovol PK40®), polyethyleneglycol-12 palm kernel glyceride (Crovol A40®), isopropyl myristate (Crodamol IPM®), isopropyl palmitate (Crodamol IPP®), sorbitan monooleate (Span 80®), oleyl alcohol (Oleyl alcohol®), polyethylene glycol 300 (Polyethylene glycol 300®), and polyoxyglyceride (Labrafil 1944®).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020080026795A KR20090101579A (en) | 2008-03-24 | 2008-03-24 | Transdermal drug delivery system containing fentanyl |
KR10-2008-0026795 | 2008-03-24 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2009119992A2 WO2009119992A2 (en) | 2009-10-01 |
WO2009119992A3 true WO2009119992A3 (en) | 2009-12-03 |
Family
ID=41114441
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2009/001399 WO2009119992A2 (en) | 2008-03-24 | 2009-03-19 | Percutaneous preparation comprising fentanyl |
Country Status (2)
Country | Link |
---|---|
KR (1) | KR20090101579A (en) |
WO (1) | WO2009119992A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10512644B2 (en) | 2007-03-12 | 2019-12-24 | Inheris Pharmaceuticals, Inc. | Oligomer-opioid agonist conjugates |
US8173666B2 (en) | 2007-03-12 | 2012-05-08 | Nektar Therapeutics | Oligomer-opioid agonist conjugates |
KR101353478B1 (en) * | 2011-11-04 | 2014-01-20 | 주식회사 동일팜텍 | Transdermal patch for administering fentanyl |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001087276A1 (en) * | 2000-05-16 | 2001-11-22 | Samyang Corporation | Hydrogel composition for transdermal drug delivery |
WO2002026217A2 (en) * | 2000-09-29 | 2002-04-04 | 3M Innovative Properties Company | Composition for the transdermal delivery of fentanyl |
US20040234584A1 (en) * | 2001-08-24 | 2004-11-25 | Walter Muller | Transdermal therapeutic system with fentanyl or related substances |
US20060013865A1 (en) * | 2002-10-18 | 2006-01-19 | Hisamitsu Pharmaceutical Co., Inc. | Transdermal patch for external use comprising fentanyl |
US20060039960A1 (en) * | 2002-05-28 | 2006-02-23 | Cordes Guenter | Plaster containing fentanyl |
-
2008
- 2008-03-24 KR KR1020080026795A patent/KR20090101579A/en not_active Ceased
-
2009
- 2009-03-19 WO PCT/KR2009/001399 patent/WO2009119992A2/en active Application Filing
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001087276A1 (en) * | 2000-05-16 | 2001-11-22 | Samyang Corporation | Hydrogel composition for transdermal drug delivery |
WO2002026217A2 (en) * | 2000-09-29 | 2002-04-04 | 3M Innovative Properties Company | Composition for the transdermal delivery of fentanyl |
US20040234584A1 (en) * | 2001-08-24 | 2004-11-25 | Walter Muller | Transdermal therapeutic system with fentanyl or related substances |
US20060039960A1 (en) * | 2002-05-28 | 2006-02-23 | Cordes Guenter | Plaster containing fentanyl |
US20060013865A1 (en) * | 2002-10-18 | 2006-01-19 | Hisamitsu Pharmaceutical Co., Inc. | Transdermal patch for external use comprising fentanyl |
Also Published As
Publication number | Publication date |
---|---|
WO2009119992A2 (en) | 2009-10-01 |
KR20090101579A (en) | 2009-09-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2010016686A3 (en) | Nanoemulsion for local administration | |
EA201170555A1 (en) | EMULSIONS WITH A MODIFIED RELEASE FOR APPLICATION TO THE SKIN COVER OR VISUAL SLIM OF | |
WO2008108286A1 (en) | Medicinal composition for transdermal absorption, medicinal composition storing unit and transdermal absorption preparation using the same | |
WO2006108405A3 (en) | Nanoparticle/active ingredient conjugate | |
CL2012002126A1 (en) | Topical pharmaceutical composition comprising 1` - {[5- (trifluoromethyl) furan-2-yl] methyl} spiro [furo [2,3-f] [1,3] benzodioxol-7,3`-indole] -2` (1`h) -one; and use to treat, a disease or condition such as neuropathic pain, surgical pain, trauma pain, chronic headache, among others. | |
WO2008120711A1 (en) | Tamibarotene capsule preparation | |
WO2010039654A3 (en) | Topical treatment of skin infection | |
WO2011059324A3 (en) | Composition for topical application, uses thereof, applicator device and kit of parts | |
WO2009119992A3 (en) | Percutaneous preparation comprising fentanyl | |
WO2008025830A3 (en) | Pharmaceutical and sunscreen compositions comprising caspase-14 | |
WO2009129453A3 (en) | Clonidine formulation in a polyorthoester carrier | |
GB0514344D0 (en) | Light protecting-effective cosmetic or dermatological preparations | |
ATE533509T1 (en) | HEART-SLOWING DRUG WITH SHORT-TERM BETA-BLOCKERS AS ACTIVE INGREDIENTS | |
WO2011052935A3 (en) | Composition for lowering blood sugar, comprising extract of smilax chine l., momordica charantia and cordyceps militaris as active ingredient | |
NZ594486A (en) | Narcotic emulsion opioid analgesic formulations for treatment of cancer pain | |
WO2004071402A3 (en) | STABLE PHARMACEUTICAL DOSAGE FORM COMPRISING HMG-CoA REDUCTASE INHIBITOR | |
WO2007071205A3 (en) | A taxane derivative containing pharmaceutical composition with improved therapeutic efficacy | |
TW200719902A (en) | Solid transdermal therapeutic system with uv absorber | |
WO2008125771A3 (en) | Cosmetic use of a debaryomyces hansenii extract | |
IL177938A0 (en) | Pharmaceutical preparation containing drospirenone for application to the sking | |
MX2007013449A (en) | Depigmenting or brightening cosmetic composition comprising at least one oxazolin as an active ingredient. | |
WO2007080117A3 (en) | Phyllosilicate formulations for the controlled release of active substances | |
BRPI0518554A2 (en) | use of a pde3 inhibitor | |
GEP20135857B (en) | Emollient composition for atopic dermatitis preventive treatment | |
ATE529127T1 (en) | PHARMACEUTICAL COMPOSITION CONTAINING ARAZYM FOR THE PREVENTION OF LIVER FUNCTION DISORDER |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09724849 Country of ref document: EP Kind code of ref document: A2 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 09724849 Country of ref document: EP Kind code of ref document: A2 |